Analyst Ratings for Q32 Bio Inc. (QTTB)
QTTB Rating Summary
QTTB Price Target Summary
- Highest: $59.00 (Wells Fargo)
- Lowest: $34.00 (Morgan Stanley)
- Average: $41.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$41.00 (+185.5%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/24/2026 | Morgan Stanley | Judah Frommer | New Coverage | Overweight (N/A) |
34.00 (N/A) |
15.86 (14.36) |
-9.46% | Details |
| 7/13/2026 | Wells Fargo » Updated 8/6/2026 |
Derek Archila | Upgrade | Overweight (Equal Weight) |
59.00 (66.00) |
11.21 (14.36) |
28.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
